The Normal Reference Values of Pulse Oximetry Plethymographic Waveform

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Amplitude
Area Under Curve
Pulse Oximetry Plethymographic Waveform

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05114551` - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
Completed	`NCT03857230` - The Safety and Pharmacokinetics of Primapur and Gonal-f	Phase 1
Not yet recruiting	`NCT06095895` - Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
Completed	`NCT04756895` - Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05114551 - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure

Completed

NCT03857230 - The Safety and Pharmacokinetics of Primapur and Gonal-f

Phase 1

Not yet recruiting

NCT06095895 - Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment

Completed

NCT04756895 - Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02292420
Study type	Observational
Source	Peking Union Medical College Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 2014
Completion date	February 2015

The Normal Reference Values of Pulse Oximetry Plethymographic Waveform Parameters

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms